Searched for
ADVANCED THERAPEUTICS
Karnataka explores biotech financing framework, AI-led innovation to support sector growthKarnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...16 Jun, 2026, 09.52 PM IST- Two Egyptian mummies were scanned in Los Angeles with half-millimeter precision, and doctors found something they weren't expecting in a 2,200-year-old spineAncient Egyptian mummies, Nes-Min and Nes-Hor, underwent advanced CT scans at Keck Hospital, revealing a unique spinal trepanation on Nes-M...12 Jun, 2026, 03.09 PM IST
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.08 Jun, 2026, 07.40 PM IST
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...08 Jun, 2026, 01.27 PM IST
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...05 Jun, 2026, 05.36 PM IST
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...03 Jun, 2026, 02.36 PM IST
- Weather swings, monsoon risks, and the growing threat to mango, apple cropsThe agriculture industry has evolved historically through adaptation and resilience, and now it is time to speed up this transformation, em...01 Jun, 2026, 11.43 AM IST
- Sir H.N. Reliance Foundation Hospital Claims Top Spot In Nationwide Critical Care SurveySir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...30 May, 2026, 05.40 PM IST
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...30 May, 2026, 10.35 AM IST
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...30 May, 2026, 12.52 AM IST
- India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...28 May, 2026, 08.05 AM IST
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...27 May, 2026, 08.27 PM IST
- "India has scientific capability to emerge as global leader in health technologies": NITI Aayog's Gobardhan DasIndia's largest biomedical event, 'Medical Innovations Patent Mitra: Innovators-to-Industry Connect', successfully took place in New Delhi....25 May, 2026, 07.53 PM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...20 May, 2026, 12.18 PM IST
Load More
